Global Drug Eluting Beads Market by Type (Oncozene Beads, Quadra Sphere, LC Beads, Others), By Application (Hospitals, Specialized Clinics, Research Centers, Ambulatory Surgical Centers) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug Eluting Beads Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drug Eluting Beads Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drug Eluting Beads Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drug Eluting Beads Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drug Eluting Beads Market Size & Forecast, 2018-2028
4.5.1 Drug Eluting Beads Market Size and Y-o-Y Growth
4.5.2 Drug Eluting Beads Market Absolute $ Opportunity
Chapter 5 Global Drug Eluting Beads Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Drug Eluting Beads Market Size Forecast by Type
5.2.1 Oncozene Beads
5.2.2 Quadra Sphere
5.2.3 LC Beads
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Drug Eluting Beads Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Drug Eluting Beads Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialized Clinics
6.2.3 Research Centers
6.2.4 Ambulatory Surgical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drug Eluting Beads Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drug Eluting Beads Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Drug Eluting Beads Analysis and Forecast
9.1 Introduction
9.2 North America Drug Eluting Beads Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Drug Eluting Beads Market Size Forecast by Type
9.6.1 Oncozene Beads
9.6.2 Quadra Sphere
9.6.3 LC Beads
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Drug Eluting Beads Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialized Clinics
9.10.3 Research Centers
9.10.4 Ambulatory Surgical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Drug Eluting Beads Analysis and Forecast
10.1 Introduction
10.2 Europe Drug Eluting Beads Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Drug Eluting Beads Market Size Forecast by Type
10.6.1 Oncozene Beads
10.6.2 Quadra Sphere
10.6.3 LC Beads
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Drug Eluting Beads Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialized Clinics
10.10.3 Research Centers
10.10.4 Ambulatory Surgical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Drug Eluting Beads Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Drug Eluting Beads Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Drug Eluting Beads Market Size Forecast by Type
11.6.1 Oncozene Beads
11.6.2 Quadra Sphere
11.6.3 LC Beads
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Drug Eluting Beads Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialized Clinics
11.10.3 Research Centers
11.10.4 Ambulatory Surgical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Drug Eluting Beads Analysis and Forecast
12.1 Introduction
12.2 Latin America Drug Eluting Beads Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Drug Eluting Beads Market Size Forecast by Type
12.6.1 Oncozene Beads
12.6.2 Quadra Sphere
12.6.3 LC Beads
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Drug Eluting Beads Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialized Clinics
12.10.3 Research Centers
12.10.4 Ambulatory Surgical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Drug Eluting Beads Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Drug Eluting Beads Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Drug Eluting Beads Market Size Forecast by Type
13.6.1 Oncozene Beads
13.6.2 Quadra Sphere
13.6.3 LC Beads
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Drug Eluting Beads Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialized Clinics
13.10.3 Research Centers
13.10.4 Ambulatory Surgical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drug Eluting Beads Market: Competitive Dashboard
14.2 Global Drug Eluting Beads Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Biocompatibles
14.3.2 BTG International
14.3.3 Merit Medical Systems
14.3.4 CeloNova BioSciences
14.3.5 ABK Biomedical
14.3.6 Boston Scientific
14.3.7 Medtronic
14.3.8 Merit Medical Systems
14.3.9 Surefire Medical
14.3.10 Terumo